» Articles » PMID: 36787443

The Context-dependent Role of Transforming Growth Factor-β/miR-378a-3p/connective Tissue Growth Factor in Vascular Calcification: a Translational Study

Overview
Specialty Geriatrics
Date 2023 Feb 14
PMID 36787443
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Vascular calcification (VC) constitutes an important vascular pathology with prognostic importance. The pathogenic role of transforming growth factor-β (TGF-β) in VC remains unclear, with heterogeneous findings that we aimed to evaluate using experimental models and clinical specimens.

Methods: Two approaches, exogenous administration and endogenous expression upon osteogenic media (OM) exposure, were adopted. Aortic smooth muscle cells (ASMCs) were subjected to TGF-β1 alone, OM alone, or both, with calcification severity determined. We evaluated miR-378a-3p and TGF-β1 effectors (connective tissue growth factor; CTGF) at different periods of calcification. Results were validated in an model and further in sera from older adults without or with severe aortic arch calcification.

Results: TGF-β1 treatment induced a significant dose-responsive increase in ASMC calcification without or with OM at the mature but not early or mid-term VC period. On the other hand, OM alone induced VC accompanied by suppressed TGF-β1 expressions over time; this phenomenon paralleled the declining miR-378a-3p and CTGF expressions since early VC. TGF-β1 treatment led to an upregulation of CTGF since early VC but not miR-378a-3p until mid-term VC, while miR-378a-3p overexpression suppressed CTGF expressions without altering TGF-β1 levels. The OM-induced down-regulation of TGF-β1 and CTGF was also observed in the models, with compatible results identified from human sera.

Conclusions: We showed that TGF-β1 played a context-dependent role in VC, involving a time-dependent self-regulatory loop of TGF-β1/miR-378a-3p/CTGF signaling. Our findings may assist subsequent studies in devising potential therapeutics against VC.

Citing Articles

Profibrotic role of transcription factor SP1 in cross-talk between fibroblasts and M2 macrophages.

Feng P, Che Y, Gao C, Chu X, Li Z, Li L iScience. 2023; 26(12):108484.

PMID: 38094246 PMC: 10716550. DOI: 10.1016/j.isci.2023.108484.

References
1.
Dellegrottaglie S, Saran R, Rajagopalan S . Vascular calcification in patients with renal failure: culprit or innocent bystander?. Cardiol Clin. 2005; 23(3):373-84. DOI: 10.1016/j.ccl.2005.04.001. View

2.
Shang X, Scott D, Hodge A, Khan B, Khan N, English D . Adiposity assessed by anthropometric measures has a similar or greater predictive ability than dual-energy X-ray absorptiometry measures for abdominal aortic calcification in community-dwelling older adults. Int J Cardiovasc Imaging. 2016; 32(9):1451-1460. DOI: 10.1007/s10554-016-0920-2. View

3.
Huang J, Huang H, Wu M, Li J, Xie H, Zhou H . Connective tissue growth factor induces osteogenic differentiation of vascular smooth muscle cells through ERK signaling. Int J Mol Med. 2013; 32(2):423-9. DOI: 10.3892/ijmm.2013.1398. View

4.
Rodriguez A, Scott D, Khan B, Khan N, Hodge A, English D . Low Relative Lean Mass is Associated with Increased Likelihood of Abdominal Aortic Calcification in Community-Dwelling Older Australians. Calcif Tissue Int. 2016; 99(4):340-9. DOI: 10.1007/s00223-016-0157-z. View

5.
Kanazawa S, Miyake T, Kakinuma T, Tanemoto K, Tsunoda T, Kikuchi K . The expression of platelet-derived growth factor and connective tissue growth factor in different types of abdominal aortic aneurysms. J Cardiovasc Surg (Torino). 2005; 46(3):271-8. View